Sulfamonomethoxine
規格
1220-83-3CAS番号
624-483-8EC番号
4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamideIUPAC名
C11H12N4O3S化学式
280.31 g/mol分子量
sulfamonomethoxine; 1220-83-3; Daimeton; 4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide; Sulfamonometoxina; Sulfamonomethoxinum; Benzenesulfonamide, 4-amino-N-(6-methoxy-4-pyrimidinyl)-; DTXSID8045351; NSC-757862; U700P169W2; DTXCID6025351; RefChem:932367; 624-483-8; Sulfamonomethoxin; Sulfamonmethoxine; 4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide; 4-amino-N-(6-methoxypyrimidin-4-yl)benzene-1-sulfonamide; 4-METHOXY-6-SULFANILAMIDOPYRIMIDINE; MFCD00063466; CHEBI:32164; NCGC00016572-01; 4-AMINO-N-(6-METHOXY-4-PYRIMIDINYL)-BENZENESULFONAMIDE; CAS-1220-83-3; Daimeton (TN); DS-36; DJ-1550; ICI 32525; Ro 4-3476; SMM; N1-?(6-?Methoxy-?4-?pyrimidinyl)?sulfanilamide; 4-?Methoxy-?6-?sulfanilamidopyrimidine, 4-Amino-N-?(6-?methoxy-?4-?pyrimidinyl)?benzenesulfonamide; SMR000036718; Sulfamonomethoxinum [INN-Latin]; Sulfamonometoxina [INN-Spanish]; N1-(6-Methoxy-4-pyrimidinyl)sulfanilamide; SR-01000000177; [(4-aminophenyl)sulfonyl](6-methoxypyrimidin-4-yl)amine; BRN 0621128; Sulfamonomethoxine [USAN:INN:BAN:JAN]; UNII-U700P169W2; Prestwick_105; Spectrum_001414; Prestwick0_000823; Prestwick1_000823; Prestwick2_000823; Prestwick3_000823; Spectrum2_001421; Spectrum3_000913; Spectrum4_001012; Spectrum5_000985; Epitope ID:952456; N(sup 1)-(6-Methoxy-4-pyrimidinyl)sulfanilamide; Oprea1_147724; SCHEMBL93784; BSPBio_000745; KBioGR_001503; KBioSS_001894; Sulfamonomethoxine (Standard); 5-25-12-00493 (Beilstein Handbook Reference); MLS000069737; MLS000079369; DivK1c_000949; SPECTRUM1501147; SPBio_001522; SPBio_002666; BPBio1_000821; CHEMBL462990; orb1226765; orb1310373; orb3025067; Sulfanilamide, N(sup 1)-(6-methoxy-4-pyrimidinyl)-; SULFAMONOMETHOXINE [INN]; SULFAMONOMETHOXINE [JAN]; SCHEMBL29362359; Sulfamonomethoxine-13C6 Hydrate; GTPL12688; HMS502P11; HY-B0946R; KBio1_000949; KBio2_001894; KBio2_004462; KBio2_007030; KBio3_001886; MSK4040C6; SULFAMONOMETHOXINE [USAN]; NINDS_000949; WMPXPUYPYQKQCX-UHFFFAOYSA-N; GLXC-10378; HMS1570F07; HMS1921J21; HMS2092H07; HMS2097F07; HMS3714F07; HMS5081D14; Pharmakon1600-01501147; SULFAMONOMETHOXINE [MART.]; Ro43476; SULFAMONOMETHOXINE [WHO-DD]; HY-B0946; MSK4040C6-100M; Sulfamonomethoxine (JAN/USAN/INN); Tox21_110502; BBL023014; CCG-38995; MSK4040-100M; MSK4040C6-1000M; NSC757862; s3644; SBB001134; STL089636; AKOS000308735; MSK4040-1000M; Tox21_110502_1; CS-4419; NSC 757862; IDI1_000949; NCGC00016572-02; NCGC00016572-03; NCGC00016572-04; NCGC00016572-05; NCGC00016572-06; NCGC00016572-07; NCGC00016572-08; NCGC00016572-12; NCGC00023060-04; NCGC00023060-05; AC-14922; AS-70089; DA-58176; N-(6-Methoxy-4-pyrimidinyl)sulfanilamide; ST007533; SBI-0051659.P002; DB-041649; AB00052221; NS00009596; S0592; T0699; C71832; D01141; Sulfamonomethoxine 100 |Ig/mL in Acetonitrile; AB00052221-12; AB00052221_14; Sulfamonomethoxine 100 microg/mL in Acetonitrile; F799611; Sulfamonomethoxine 1000 microg/mL in Acetonitrile; Sulfamonomethoxine Solution in Methanol, 100ug/mL; SR-01000000177-3; SR-01000000177-4; Sulfamonomethoxine Solution in Methanol, 1000ug/mL; BRD-K14116214-001-04-7; BRD-K14116214-001-07-0; BRD-K14116214-001-09-6; Q27114805; Sulfamonomethoxine, VETRANAL(TM), analytical standard; 4-amino-N-(6-methoxy-pyrimidin-4-yl)-benzenesulfonamide; Sulfamonomethoxine-13C6 Solution in Methanol, 100ug/mL; Sulfamonomethoxine-13C6 Solution in Methanol, 1000ug/mL; K4Y別名